JAFCO Group — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
CADDi builds an AI data platform for the manufacturing industry, alongside a procurement platform for custom (made-to-order) parts, using data and AI to unlock knowledge from the production floor.
Advanced ManufacturingAI & Machine LearningB2B MarketplacesSaaSTokyo, JP
Yushiro Kato(Founder)in加藤 勇志郎(代表取締役CEO・共同創業者)Aditya Sastry(Founder)Aki Kobashi(Founder)Alejandro Castellano(Founder)Kato Yushiro(Founder)
Co-investorsAtomicoCoreline VenturesDCM VenturesGlobal BrainGlobis Capital PartnersMinerva Growth Partners+8 more
PRD Therapeutics is a drug-discovery startup developing first-in-class oral SOAT2-selective inhibitors (PRD compounds derived from pyripyropene A) to regulate lipid metabolism.
BiotechLongevityTokyo, JP
細田 莞爾(代表取締役社長 / President & Co-Founder)供田 洋(社外取締役 / Co-Founder)
Co-investorsJIC Venture Growth InvestmentsMizuho CapitalSMBC Venture Capital
Japanese HR tech firm offering a platform that standardizes and links enterprise HR SaaS data, plus its own payroll SaaS.
Hidekazu Sugiurain
Co-investorsGlobal BrainGlobis Capital PartnersSBI InvestmentSimplex
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










